Parexel International has opened a new location in Hyderabad, India. Through this new location, PAREXEL “offers its clients a wide range of clinical research and data management services while deepening its long-term commitment in India,” according to a company statement.

“We are especially excited to be breaking ground in India’s 6th largest metropolis, which is quickly becoming an important biotechnology hub,” said Josef von Rickenbach, Parexel’s chairman and chief executive officer.

The office is staffed by locally-based key management, and a team of experts with extensive knowledge of India’s regulatory process. “Last year, Parexel entered into a joint venture arrangement with Synchron, an India-based clinical research organization, to form Parexel International Synchron Private Limited, to provide a broad range of Phase II- IV clinical research services,” said Mark A. Goldberg, M.D., president of Clinical Research Services and Perceptive Informatics, Parexel International. “The opening of our Hyderabad location was a natural next step to meet client demand in India for our services.”